NFX vs. PYC, OBD, RENE, SALV, OCTP, OVB, VAL, PEBI, ABZA, and VER
Should you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Physiomics (PYC), Oxford BioDynamics (OBD), ReNeuron Group (RENE), SalvaRx Group (SALV), Oxford Cannabinoid Technologies (OCTP), Ovoca Bio (OVB), ValiRx (VAL), Port Erin Biopharma Investments (PEBI), Abzena (ABZA), and Vernalis (VER). These companies are all part of the "biotechnology" industry.
Nuformix vs.
Nuformix (LON:NFX) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends.
Nuformix has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Physiomics has a beta of 1.69, suggesting that its stock price is 69% more volatile than the S&P 500.
Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -106.80%. Nuformix's return on equity of -27.25% beat Physiomics' return on equity.
Physiomics received 12 more outperform votes than Nuformix when rated by MarketBeat users. However, 66.67% of users gave Nuformix an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Physiomics has higher revenue and earnings than Nuformix.
In the previous week, Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.
0.1% of Nuformix shares are held by institutional investors. 12.4% of Nuformix shares are held by insiders. Comparatively, 4.2% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Nuformix beats Physiomics on 8 of the 11 factors compared between the two stocks.
Get Nuformix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuformix Competitors List
Related Companies and Tools
This page (LON:NFX) was last updated on 1/22/2025 by MarketBeat.com Staff
Free NFX Stock Alerts